Quantcast

Oregon Bio and Catalyze Team up to Host Northwest Reception at Prestigious JP Morgan Conference

PORTLAND, Ore.–(BUSINESS WIRE)–#biobeyondthebay–The Pacific Northwest’s bioscience and digital health sector will be on display ‘Beyond the Bay’ at the J.P. Morgan healthcare investor conference next week.

Oregon Bioscience Association and Catalyze are hosting the Beyond The Bay Pacific NW Networking Reception from 4-7 p.m. on January 14, 2020, at the 38th JP Morgan Healthcare Conference in San Francisco. The conference runs from Jan. 13-16. Northwest companies attending will include those in the biotechnology, digital, medical device and pharmaceutical sectors.

More than 300 people from the Pacific Northwest are slated to attend the San Francisco reception on Jan. 14.

According to conference planners, the annual JP Morgan Healthcare Conference is the largest and most informative healthcare investment symposium in the industry, bringing together industry leaders, emerging fast-growth companies, innovative technology creators, and members of the investment community.

The keynote speaker at the reception, Eric D. Hargan, the national Deputy Secretary for Health and Human Services, will give an overview of HHS’s efforts encouraging innovation. Local med-entrepreneur Ray Constantini of Bright.MD will also speak about why Portland is a great place to grow a digital health company.

“While the JP Morgan Conference is itself an exclusive event, it has spawned a global hub for healthcare investment. We’re co-hosting the Northwest’s bio and digital health reception so local attendees can connect, network, hold meetings and create partnerships,” said Liisa Bozinovic, Oregon Bio’s Executive Director. She added, “Oregon Bio is excited to support the continued growth of bioscience in the Pacific Northwest.” Oregon Bio, Catalyze and partnering sponsors are expecting hundreds of biotech-focused investors and industry experts at the Pacific Northwest networking reception.

Reception co-organizer Charla Triplett, Founder and President of Catalyze, said, “We saw a real need to help connect local startups with early-stage capital.” She added, “This event is a way to reach out and create awareness about the opportunity for unique deal flow existing here in the Pacific Northwest. These efforts are a part of a larger push to support the Medtech and Digital Health Innovation Zone forming in the Portland area.”

The Pacific Northwest Networking Reception is also sponsored by Oregon Bioscience Incubator, Summit Development Group, Oregon State University’s College of Engineering, Aventurine, Cambia Grove, Washington State Department of Commerce, Make & Scale and VectorPoint Ventures. To register for the reception, click here – https://www.eventbrite.com/e/beyond-the-bay-networking-reception-at-the-jpm-healthcare-conference-tickets-85454918963.

Pacific Northwest healthcare changemakers and entrepreneurs will be promoted and provided an opportunity to connect with regional, national and international venture capitalists, angels, accelerators and corporate venture capitalists in health care, medtech, pharma and digital health.

Successful entrepreneurs from Oregon and Washington will offer brief remarks and one of our sponsors, Cambia Grove, will engage attendees in an informal dialogue about how we, as changemakers, can work together to create a person-focused and economically sustainable health care system. The reception offers locally-sourced Pacific Northwest wine, beer and seasonal artisan delights.

Pre-registration for the reception is required. Call (503) 548-4432 for more information.

About Oregon Bio (https://oregonbio.org)

The Oregon Bioscience Association seeks to create opportunity through advocacy, cultivation, education and group purchasing discounts for its members and the sector. Oregon Bio promotes the growth and quality of the bioscience industry in the region and continually seeks ways to support sustainability, acceleration and growth in the life science, bioscience, biotechnology and device manufacturing industries. Oregon Bio, a nonprofit membership association, affiliates with the Biotechnology Innovation Organization (BIO), and the Advanced Medical Technology Association.

The region’s most current bioscience economic impact study showed in 2017 Oregon’s growing bio footprint reached $10.7 billion, creating 47,238 jobs for $1.5 billion in wages across 820 business establishments. Between 2002-2017, total bioscience employment in Oregon jumped 72 percent among the five industry subsectors. Health-related R&D at Oregon hospitals and universities generated $669 million in economic activity in 2017. In 2015, federal research funding to Oregon institutions totaled more than $363 million. Venture capital investments in Oregon’s bioscience-related companies have increased in recent years and between 2014 to 2017, totaled $76.5 million.

Also growing is Oregon’s share of NIH funding. A 2018 report released by BIO shows Oregon attracted 1,274 bioscience and related patents. The study also found Oregon is emerging in several bioscience areas, with job growth in four of the five major subsectors from 2007 to 2016.

For more information about Oregon Bioscience Association, please visit www.oregonbio.org. Connect with us on LinkedIn and Twitter.

About Catalyze (https://www.catalyzecollective.com/)

Catalyze was founded in 2019 with the single mission to support innovation. Our consulting collective works with startups, corporate innovation groups, universities and nonprofits. At Catalyze, we approach each client with fresh eyes to develop customized, unique strategies. We have consultants and strategic partners that can support business, marketing, strategy and product development needs, with strong expertise in the medical device, digital health, technology, education and nonprofit spaces.

Contacts

Dianne Danowski Smith, (503) 201-7019, @OregonBio

Read the full article

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.